High Vista Strategies LLC Verve Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $242 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$17.85 - $40.7 $635,460 - $1.45 Million
35,600 New
35,600 $688,000
Q2 2022

Aug 15, 2022
SELL
$11.14 - $23.17 $156,773 - $326,071
-14,073 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$20.92 - $39.36 $98,512 - $185,346
-4,709 Reduced 25.07%
14,073 $321,000
Q3 2021

Nov 15, 2021
BUY
$46.0 - $73.99 $863,972 - $1.39 Million
18,782 New
18,782 $883,000

Others Institutions Holding VERV

# of Institutions
179
Shares Held
70.3M
Call Options Held
124K
Put Options Held
244K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $514M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email